490
Participants
Start Date
October 31, 2001
Primary Completion Date
August 31, 2002
Study Completion Date
August 31, 2002
telmisartan, valsartan
Harleysville Medical Associates, Harleysville
University of Maryland/Nephrology Clinical Research Unit, Baltimore
So. Clinical Research and Management, Inc., Augusta
Orlando Clinical Research Center, Orlando
Alan Graff, Fort Lauderdale
Greater Ft. Lauderdale Heart Group Research, Fort Lauderdale
UW Health/Physicians Plus Center for Clinical Trials, Madison
Rush Presbyterian/St. Luke's Medical Center, Chicago
Washington University, St Louis
Oklahoma Cardiovascular and Hypertension Center, Oklahoma City
Trinity Hypertension Research Institute/Punzi Medical Center, Carrollton
National Research Institute, Los Angeles
Memorial Research Medical Clinic, Long Beach
Orange County Research Center, Orange
Michael A. Azorr, M.D., Portland
University of Conn. Health Services Center, Hypertension and Vascular Disease, Farmington
Heart Health Institute, Calgary
Dr. Dennis O'Keefe, Mount Pearl
Dr. William Booth, Antigonish
MSHJ Research Assoc., Halifax
Dr. Joseph Berlingieri, Burlington
Dr. William Mahoney, Corunna
BBM Clinical Research Ltd., Courtice
Dr. Richard Tytus, Hamilton
Total Concept Health Care, Kitchener
Centre for Activity and Aging, London
Dr. Martyn Chilvers, Sarnia
Sunnybrook & Women's College Health Centre, Toronto
Theradev Clinical Research, Inc., Granby
Invascor, Longueuil, Longueuil
Hotel Dieu de St-Jerome, Saint-Jérôme
Centre de Cardiologie, Saint-Lambert
Centre Hospital Quebec - PAC CHUL Unite de Recherche, Sainte-Foy
Q&T Research, Sherbrooke
Royal University Hospital, Saskatoon
Lead Sponsor
Collaborators (2)
GlaxoSmithKline
INDUSTRY
Bayer
INDUSTRY
Boehringer Ingelheim
INDUSTRY